Healthcare provider profile · identity verified

Michelle Kaye Manning, MD

Family Practice · LINCOLN, NE · NPI 1326154709

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	654	177
Amlodipine Besylate	Amlodipine Besylate	424	112
Levothyroxine Sodium	Levothyroxine Sodium	424	98
Losartan Potassium	Losartan Potassium	289	77
Omeprazole	Omeprazole	186	50
Lisinopril	Lisinopril	182	58
Pantoprazole Sodium	Pantoprazole Sodium	176	42
Gabapentin	Gabapentin	164	38
Metformin Hcl Er	Metformin Hcl	155	41
Tramadol Hcl	Tramadol Hcl	141	28
Meloxicam	Meloxicam	136	38
Duloxetine Hcl	Duloxetine Hcl	120	29
Citalopram Hbr	Citalopram Hydrobromide	111	32
Metoprolol Succinate	Metoprolol Succinate	110	33
Metoprolol Tartrate	Metoprolol Tartrate	108	30
Alendronate Sodium	Alendronate Sodium	106	31
Fluticasone Propionate	Fluticasone Propionate	90	29
Rosuvastatin Calcium	Rosuvastatin Calcium	89	25
Pravastatin Sodium	Pravastatin Sodium	87	18
Simvastatin	Simvastatin	80	22
Tamsulosin Hcl	Tamsulosin Hcl	80	22
Sertraline Hcl	Sertraline Hcl	76	17
Furosemide	Furosemide	74	25
Irbesartan	Irbesartan	74	22
Valsartan	Valsartan	74	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	69	17
Potassium Chloride	Potassium Chloride	66	14
Warfarin Sodium	Warfarin Sodium	65	11
Montelukast Sodium	Montelukast Sodium	64	19
Carvedilol	Carvedilol	61	19
Hydrochlorothiazide	Hydrochlorothiazide	61	20
Escitalopram Oxalate	Escitalopram Oxalate	57	14
Mirtazapine	Mirtazapine	53	suppressed
Spironolactone	Spironolactone	52	12
Fluoxetine Hcl	Fluoxetine Hcl	50	16
Allopurinol	Allopurinol	49	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	20
Glipizide	Glipizide	48	14
Lorazepam	Lorazepam	46	12
Eliquis	Apixaban	45	suppressed
Prednisone	Prednisone	45	23
Xarelto	Rivaroxaban	43	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	12
Lamotrigine	Lamotrigine	38	suppressed
Clonidine Hcl	Clonidine Hcl	37	suppressed
Mounjaro	Tirzepatide	37	suppressed
Bupropion Hcl Sr	Bupropion Hcl	36	suppressed
Buspirone Hcl	Buspirone Hcl	36	suppressed
Metformin Hcl	Metformin Hcl	36	11
Shingrix	Varicella-Zoster Ge/As01b/Pf	35	30
Albuterol Sulfate Hfa	Albuterol Sulfate	34	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Celecoxib	Celecoxib	33	suppressed
Clonazepam	Clonazepam	33	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Trazodone Hcl	Trazodone Hcl	33	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	32	suppressed
Famotidine	Famotidine	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Ozempic	Semaglutide	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	20
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Estradiol	Estradiol	26	16
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Atenolol	Atenolol	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	23	suppressed
Jardiance	Empagliflozin	22	suppressed
Colestipol Hcl	Colestipol Hcl	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Alprazolam	Alprazolam	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Naproxen	Naproxen	20	suppressed
Baclofen	Baclofen	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Ramipril	Ramipril	17	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Amoxicillin	Amoxicillin	14	11
Aripiprazole	Aripiprazole	14	suppressed
Cephalexin	Cephalexin	14	14
Colesevelam Hcl	Colesevelam Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Ibuprofen	Ibuprofen	13	suppressed
Methylprednisolone	Methylprednisolone	13	13
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Anastrozole	Anastrozole	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error